XERIS BIOPHARMA HLDGS INC COM USD0.0001 financial statements, including revenue, expenses, profit, and loss

The total revenue of 0A8E for the last quarter is 44.39 M USD, and it's 8.13% lower compared to the previous quarter. The net income of Q4 23 is -13.39 M USD.